INCOGEN Completes NIH Funded BISTI Project
Feb. 17, 2023
Courtesy ofIncogen, Inc.
INCOGEN and its collaborators announced the completion of the five-year long clear cell renal cell carcinoma (ccRCC) project. This multidisciplinary project was funded by several National Cancer Institute Small Business Innovation Research (SBIR) grants and involved collaborations with the Mayo Clinic, Eastern Virginia Medical School, and Johns Hopkins University. It resulted in the development and refinement of bioinformatics analysis tools as well as several potential diagnostic and prognostic renal cancer markers.
Stay in the loop!
Select your areas of interest to receive industry updates.